Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)

Clinical trial NCT00379470 · COMPLETED

Trial details

NCT number: NCT00379470
Sponsor: NovoCure Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Glioblastoma Multiforme

Start date: 2006-09-01
Primary completion: 2009-11-01
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.